IFNA1 and cancer: The discovery of how the cyclic GMP-AMP synthase/stimulator of interferon (IFN) genes/IFN (cGAS/STING/IFN) pathway augments antitumor immunity via enrichment of an immune-suppressive TME may lead to further breakthroughs in cancer immunotherapy (23, 24).